Nifty

:

14529.15

Sensex

:

49099.99

-568.20 (-3.76%)
-1939.32 (-3.80%)

Login

Nifty
Sensex

:
:

14529.15
49099.99

-568.20 (-3.76%)
-1939.32 (-3.80%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

64/99

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

1118.60

26-Feb-2021

Open
High
Low
Previous Close

1130.00
1206.30
1107.05
1138.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

239015
2759.05
1263.00
415.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,634.34
21.72
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,635.43
0.98%
5.31

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.14
7.58
7.87

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.98
12.88
13.65

PAT CAGR (%)

10 Years
5 Years
3 Years

6.92
11.04
25.28

P:E (Median)

8 Years
5 Years
3 Years

17.77
17.21
17.81

P:BV (Average)

8 Years
5 Years
3 Years

2.12
2.52
2.68

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.91
10.73
10.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 500.34 384.96 29.97% 411.78 428.12 -3.82% 489.62 410.80 19.19% 416.86 379.15 9.95%
Expenses 333.74 300.87 10.92% 306.04 327.36 -6.51% 331.47 318.55 4.06% 325.73 319.23 2.04%
EBITDA 166.60 84.08 98.14% 105.74 100.76 4.94% 158.15 92.25 71.44% 91.14 59.92 52.10%
EBIDTM 33.30% 21.84% 25.68% 23.54% 32.30% 22.46% -0.29% 15.80%
Other Income 55.86 16.02 248.69% 8.19 18.11 -54.78% 22.54 12.34 82.66% 2.88 15.29 -81.16%
Interest 1.08 0.85 27.06% 1.70 0.87 95.40% 3.73 0.80 366.25% 0.40 1.31 -69.47%
Depreciation 17.05 16.55 3.02% 17.14 16.22 5.67% 16.97 15.63 8.57% 16.69 11.41 46.28%
PBT 204.33 82.70 147.07% 95.09 101.77 -6.56% 159.99 88.16 81.48% 66.92 62.50 7.07%
Tax 52.66 20.53 156.50% 24.11 5.82 314.26% 38.07 29.01 31.23% 16.05 20.32 -21.01%
PAT 151.67 62.17 143.96% 70.98 95.96 -26.03% 121.92 59.15 106.12% 50.87 42.18 20.60%
PATM 30.31% 16.15% 17.24% 22.41% 24.90% 14.40% 2.87% 11.12%
EPS 19.62 8.04 144.03% 9.18 12.41 -26.03% 15.77 7.65 106.14% 6.58 5.46 20.51%

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 548.22 428.63 27.90% 443.56 456.42 -2.82% 522.29 446.11 17.08% 443.57 418.91 5.89%
Expenses 377.22 339.04 11.26% 333.47 356.16 -6.37% 366.86 350.13 4.78% 351.83 353.38 -0.44%
EBITDA 170.99 89.59 90.86% 110.10 100.26 9.81% 155.42 95.98 61.93% 91.74 65.54 39.98%
EBIDTM 31.19% 20.90% 24.82% 21.97% 29.76% 21.51% 14.01% 15.65%
Other Income 55.95 16.38 241.58% 8.39 18.51 -54.67% 22.69 12.61 79.94% 3.17 15.65 -79.74%
Interest 1.09 0.85 28.24% 1.72 0.87 97.70% 3.75 0.80 368.75% 0.50 1.31 -61.83%
Depreciation 17.39 16.75 3.82% 17.45 16.39 6.47% 17.29 15.80 9.43% 17.39 11.60 49.91%
PBT 208.46 88.37 135.89% 99.33 101.51 -2.15% 157.07 91.99 70.75% 67.02 68.28 -1.85%
Tax 54.18 21.93 147.06% 25.41 7.75 227.87% 37.57 29.87 25.78% 16.95 21.49 -21.13%
PAT 154.28 66.45 132.17% 73.92 93.76 -21.16% 119.51 62.11 92.42% 50.07 46.79 7.01%
PATM 28.14% 15.50% 16.67% 20.54% 22.88% 13.92% 7.11% 11.17%
EPS 19.94 8.26 141.40% 9.55 11.67 -18.17% 15.45 7.73 99.87% 28.29 5.82 386.08%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,818.60 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 1,061.42 956.53 816.42 686.42 806.69 Net Sales Growth 13.45% 9.30% 19.62% 4.70% 2.90% 9.75% 10.97% 17.16% 18.94% -14.91% Cost Of Goods Sold 951.11 569.14 536.35 484.27 469.32 470.01 322.91 380.72 341.32 271.40 246.12 Gross Profit 867.49 1,071.61 964.83 770.72 729.38 694.93 738.51 575.81 475.10 415.02 560.57 GP Margin 47.70% 65.31% 64.27% 61.41% 60.85% 59.65% 69.58% 60.20% 58.19% 60.46% 69.49% Total Expenditure 1,296.98 1,272.50 1,212.75 1,072.79 980.15 939.21 868.48 802.49 705.00 622.22 638.78 Power & Fuel Cost - 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 29.89 23.34 % Of Sales - 3.75% 4.22% 4.64% 4.58% 4.75% 5.00% 4.87% 4.87% 4.35% 2.89% Employee Cost - 293.78 257.98 217.31 187.86 165.96 146.82 131.85 120.13 101.31 116.43 % Of Sales - 17.91% 17.19% 17.32% 15.67% 14.25% 13.83% 13.78% 14.71% 14.76% 14.43% Manufacturing Exp. - 129.40 139.89 130.97 122.68 119.24 223.30 102.28 61.62 52.90 60.66 % Of Sales - 7.89% 9.32% 10.44% 10.23% 10.24% 21.04% 10.69% 7.55% 7.71% 7.52% General & Admin Exp. - 46.11 49.84 49.82 39.08 32.06 29.92 28.78 25.76 27.03 24.49 % Of Sales - 2.81% 3.32% 3.97% 3.26% 2.75% 2.82% 3.01% 3.16% 3.94% 3.04% Selling & Distn. Exp. - 106.58 104.91 59.44 48.83 48.13 47.39 70.48 55.49 59.10 124.32 % Of Sales - 6.50% 6.99% 4.74% 4.07% 4.13% 4.46% 7.37% 6.80% 8.61% 15.41% Miscellaneous Exp. - 65.96 60.48 72.71 57.49 48.54 45.12 41.78 60.93 80.59 124.32 % Of Sales - 4.02% 4.03% 5.79% 4.80% 4.17% 4.25% 4.37% 7.46% 11.74% 5.38% EBITDA 521.63 368.24 288.44 182.20 218.54 225.73 192.94 154.04 111.42 64.20 167.91 EBITDA Margin 28.68% 22.44% 19.21% 14.52% 18.23% 19.38% 18.18% 16.10% 13.65% 9.35% 20.81% Other Income 89.47 49.57 40.23 56.21 49.51 55.68 10.41 37.54 25.96 28.51 5.88 Interest 6.91 3.16 4.57 3.41 5.00 10.29 6.65 5.93 5.24 21.78 10.19 Depreciation 67.85 65.09 54.82 55.95 46.26 40.41 37.60 27.17 24.40 22.30 22.65 PBT 526.33 349.56 269.28 179.04 216.78 230.69 159.10 158.49 107.74 48.63 140.95 Tax 130.89 71.42 87.22 51.04 43.82 51.49 45.52 25.56 22.81 166.52 22.76 Tax Rate 24.87% 21.03% 32.39% 28.51% 20.21% 22.32% 28.61% 27.19% 21.17% 20.58% 16.15% PAT 395.44 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 642.70 118.19 PAT before Minority Interest 395.44 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 642.70 118.19 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 21.74% 16.34% 12.13% 10.20% 14.43% 15.38% 10.70% 7.15% 10.40% 93.63% 14.65% PAT Growth 52.41% 47.28% 42.23% -25.99% -3.48% 57.77% 65.98% -19.44% -86.78% 443.79% EPS 51.16 34.69 23.55 16.56 22.38 23.18 14.69 8.85 10.99 83.14 15.29

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,957.64 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 1,144.21 1,021.86 866.13 801.87 890.79 Net Sales Growth 11.86% 8.00% 16.23% 3.32% 11.10% 7.64% 11.97% 17.98% 8.01% -9.98% Cost Of Goods Sold 5,151.08 630.80 596.46 542.41 552.00 491.41 341.40 413.95 371.52 320.07 277.04 Gross Profit -3,193.44 1,143.93 1,046.74 871.35 816.32 740.17 802.81 607.92 494.60 481.80 613.75 GP Margin -163.13% 64.46% 63.70% 61.63% 59.66% 60.10% 70.16% 59.49% 57.10% 60.08% 68.90% Total Expenditure 1,429.38 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 964.09 873.67 760.48 701.55 698.43 Power & Fuel Cost - 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 29.89 23.34 % Of Sales - 3.47% 3.85% 4.12% 4.01% 4.49% 4.63% 4.56% 4.59% 3.73% 2.62% Employee Cost - 322.92 288.18 251.10 217.34 175.31 159.56 143.67 130.05 112.66 124.93 % Of Sales - 18.20% 17.54% 17.76% 15.88% 14.23% 13.94% 14.06% 15.02% 14.05% 14.02% Manufacturing Exp. - 140.70 150.49 139.83 131.45 119.35 223.53 102.44 61.75 52.97 60.85 % Of Sales - 7.93% 9.16% 9.89% 9.61% 9.69% 19.54% 10.02% 7.13% 6.61% 6.83% General & Admin Exp. - 48.89 52.97 53.96 42.26 34.82 32.46 31.69 27.94 31.31 38.21 % Of Sales - 2.75% 3.22% 3.82% 3.09% 2.83% 2.84% 3.10% 3.23% 3.90% 4.29% Selling & Distn. Exp. - 116.95 113.59 87.44 78.27 72.72 75.13 73.59 56.04 68.65 131.60 % Of Sales - 6.59% 6.91% 6.18% 5.72% 5.90% 6.57% 7.20% 6.47% 8.56% 14.77% Miscellaneous Exp. - 75.36 72.38 81.61 59.72 76.65 79.01 61.72 73.44 86.00 131.60 % Of Sales - 4.25% 4.40% 5.77% 4.36% 6.22% 6.91% 6.04% 8.48% 10.72% 4.77% EBITDA 528.25 377.58 305.84 199.13 232.39 206.03 180.12 148.19 105.65 100.32 192.36 EBITDA Margin 26.98% 21.28% 18.61% 14.09% 16.98% 16.73% 15.74% 14.50% 12.20% 12.51% 21.59% Other Income 90.20 50.90 41.44 55.29 50.16 56.65 10.89 37.70 27.87 28.98 6.16 Interest 7.06 3.26 4.65 3.49 5.37 10.65 6.82 5.93 5.28 24.03 10.49 Depreciation 69.52 66.32 55.64 56.97 47.22 41.22 38.64 28.02 24.66 22.42 22.79 PBT 531.88 358.89 286.99 193.95 229.94 210.82 145.55 151.94 103.57 82.85 165.24 Tax 134.11 76.50 93.02 55.23 45.55 49.58 45.14 25.95 24.13 165.53 25.92 Tax Rate 25.21% 21.93% 32.41% 28.48% 19.81% 23.52% 31.01% 29.68% 23.30% 19.63% 15.69% PAT 397.78 272.04 193.47 138.34 184.06 161.14 100.41 61.50 79.44 677.91 139.32 PAT before Minority Interest 397.42 272.39 193.97 138.72 184.40 161.24 100.41 61.50 79.44 677.91 139.32 Minority Interest -0.36 -0.35 -0.50 -0.38 -0.34 -0.10 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.32% 15.33% 11.77% 9.79% 13.45% 13.08% 8.78% 6.02% 9.17% 84.54% 15.64% PAT Growth 47.81% 40.61% 39.85% -24.84% 14.22% 60.48% 63.27% -22.58% -88.28% 386.58% EPS 51.46 35.19 25.03 17.90 23.81 20.85 12.99 7.96 10.28 87.70 18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 1,016.31 1,047.81 1,009.00 953.86 713.28 Share Capital 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 16.94 16.90 Total Reserves 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 999.35 1,030.82 991.95 936.74 696.05 Non-Current Liabilities 73.29 79.08 62.98 41.79 46.07 34.05 32.56 37.45 36.35 33.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 0.40 0.54 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 11.12 11.49 Long Term Provisions 7.39 5.73 9.67 8.88 10.20 12.03 12.19 8.23 8.27 6.88 Current Liabilities 493.12 763.27 711.89 666.97 735.89 398.40 261.56 226.38 182.51 260.64 Trade Payables 111.35 111.33 100.22 79.03 68.61 62.31 51.69 51.76 33.54 44.36 Other Current Liabilities 138.29 87.05 112.90 118.08 119.03 82.60 94.00 98.41 76.70 55.70 Short Term Borrowings 32.04 25.80 28.48 48.86 174.40 104.73 81.28 36.77 55.23 133.36 Short Term Provisions 211.45 539.10 470.29 421.00 373.85 148.76 34.59 39.43 17.05 27.22 Total Liabilities 2,011.70 2,326.91 2,228.26 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 1,172.72 1,007.27 Net Block 583.21 552.11 569.91 608.69 369.35 300.87 282.21 294.37 241.01 225.20 Gross Block 1,105.15 1,011.81 979.68 963.76 679.77 571.73 510.94 497.02 421.06 386.76 Accumulated Depreciation 521.95 459.70 409.78 355.07 310.42 270.86 228.74 202.65 180.05 161.57 Non Current Assets 805.74 804.94 781.26 941.36 891.59 604.38 378.00 352.44 331.38 283.34 Capital Work in Progress 16.17 15.09 17.40 3.76 134.89 55.17 46.32 4.81 39.00 3.75 Non Current Investment 202.42 228.84 182.92 318.81 364.38 230.72 38.86 38.98 38.79 42.24 Long Term Loans & Adv. 3.59 8.31 10.00 9.22 22.63 17.62 10.62 14.28 12.58 12.16 Other Non Current Assets 0.36 0.59 1.03 0.88 0.33 0.00 0.00 0.00 0.00 0.00 Current Assets 1,205.97 1,521.97 1,446.99 1,155.26 1,113.08 844.38 963.93 920.39 841.34 723.92 Current Investments 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 298.92 81.05 Inventories 232.04 208.10 175.81 159.96 133.29 128.47 111.23 89.89 90.80 81.78 Sundry Debtors 344.24 299.85 300.54 265.10 265.67 248.49 248.05 194.64 131.21 385.45 Cash & Bank 11.56 20.77 14.95 7.20 10.71 9.06 10.80 149.11 211.36 122.92 Other Current Assets 284.31 32.49 11.20 12.23 456.13 91.58 96.59 92.07 109.05 52.72 Short Term Loans & Adv. 266.71 600.11 560.72 485.82 453.62 91.20 96.39 91.92 108.65 51.97 Net Current Assets 712.84 758.71 735.10 488.29 377.19 445.98 702.37 694.01 658.83 463.29 Total Assets 2,011.71 2,326.91 2,228.25 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 1,172.72 1,007.26

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 994.87 1,042.81 1,020.27 969.95 691.54 Share Capital 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 16.94 16.90 Total Reserves 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 977.91 1,025.82 1,003.22 952.83 674.31 Non-Current Liabilities 62.72 64.84 45.66 26.98 31.02 32.62 31.93 40.45 39.52 36.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 0.40 0.54 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 12.14 11.99 Long Term Provisions 7.39 5.73 9.67 12.56 10.43 12.03 12.19 8.23 8.27 7.71 Current Liabilities 515.77 781.54 736.50 693.46 797.22 459.75 276.27 239.48 188.32 271.33 Trade Payables 123.79 117.37 110.39 98.98 90.85 77.51 60.75 60.51 37.09 50.21 Other Current Liabilities 143.88 93.10 119.75 122.15 138.73 103.74 98.06 101.15 78.75 61.22 Short Term Borrowings 32.04 25.80 29.29 48.86 193.02 126.88 81.71 37.28 55.23 133.36 Short Term Provisions 216.06 545.27 477.06 423.47 374.61 151.62 35.76 40.54 17.26 26.54 Total Liabilities 2,016.48 2,329.30 2,226.49 2,086.29 2,013.75 1,487.24 1,351.01 1,300.20 1,197.79 999.37 Net Block 651.26 620.93 639.50 679.44 440.22 328.56 310.55 334.41 276.31 258.39 Gross Block 1,177.43 1,084.83 1,053.76 1,038.55 753.75 601.67 540.54 537.46 456.51 420.25 Accumulated Depreciation 526.17 463.89 414.25 359.10 313.53 273.11 229.99 203.06 180.19 161.85 Non Current Assets 740.83 740.80 717.89 879.15 831.58 586.31 370.37 356.49 331.58 278.78 Capital Work in Progress 16.17 15.09 17.40 3.76 134.89 55.17 46.36 4.81 39.00 3.75 Non Current Investment 69.45 95.88 49.96 185.84 231.42 184.83 2.75 2.99 3.00 3.94 Long Term Loans & Adv. 3.59 8.31 10.15 9.43 22.63 17.74 10.71 14.28 13.27 12.70 Other Non Current Assets 0.36 0.59 0.88 0.67 2.43 0.00 0.00 0.00 0.00 0.00 Current Assets 1,275.65 1,588.51 1,508.59 1,207.14 1,182.16 900.94 980.65 943.71 866.22 720.60 Current Investments 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 298.92 81.05 Inventories 274.67 243.76 213.73 200.17 187.98 150.27 134.40 104.53 101.03 111.67 Sundry Debtors 345.43 308.22 300.73 265.97 272.64 262.35 235.51 191.27 136.05 345.58 Cash & Bank 30.95 36.80 29.92 13.39 12.90 25.19 11.81 156.23 219.53 126.89 Other Current Assets 290.80 33.23 12.94 14.36 461.34 96.35 101.68 96.99 110.69 55.41 Short Term Loans & Adv. 272.33 605.85 567.50 488.30 458.83 95.97 101.48 96.84 110.29 54.66 Net Current Assets 759.88 806.97 772.10 513.68 384.94 441.19 704.37 704.23 677.90 449.27 Total Assets 2,016.48 2,329.31 2,226.48 2,086.29 2,013.74 1,487.25 1,351.02 1,300.20 1,197.80 999.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 271.57 192.63 115.87 177.58 170.87 143.03 -11.65 80.41 850.80 136.83 PBT 339.56 269.28 179.04 216.78 230.69 159.10 93.99 107.74 809.22 141.05 Adjustment 15.19 26.87 14.73 10.01 -9.63 35.94 14.11 -6.43 3.51 23.67 Changes in Working Capital 3.97 -42.44 -39.95 -0.30 1.15 -14.04 -93.19 0.67 202.58 1.62 Cash after chg. in Working capital 358.72 253.70 153.82 226.50 222.22 181.00 14.90 101.98 1,015.31 166.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -87.15 -61.08 -37.95 -48.91 -51.34 -37.97 -26.55 -21.57 -164.51 -29.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 24.18 -27.93 -23.97 -42.45 -51.69 -121.72 -138.77 -111.73 -235.86 -89.41 Net Fixed Assets -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 -69.55 -32.72 Net Investments 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 -214.42 -60.83 Others 65.34 24.69 28.51 42.52 150.23 9.30 19.12 25.99 48.11 4.14 Cash from Financing Activity -305.48 -155.66 -59.44 -164.84 -97.46 -23.06 12.12 -30.93 -526.49 4.93 Net Cash Inflow / Outflow -9.73 9.05 32.45 -29.71 21.72 -1.75 -138.31 -62.25 88.44 52.35 Opening Cash & Equivalents 16.11 7.09 -25.36 4.35 -14.50 10.80 149.11 211.36 122.92 70.57 Closing Cash & Equivalent 6.37 16.11 7.09 -25.36 7.23 9.06 10.80 149.11 211.36 122.92

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 275.37 194.33 122.92 201.13 140.41 126.66 -13.98 84.20 879.69 133.92 PBT 348.89 286.99 193.95 229.94 212.23 145.55 87.44 103.57 843.44 165.34 Adjustment 7.95 23.72 16.91 13.11 -1.40 38.51 20.75 -4.40 33.13 16.60 Changes in Working Capital 9.32 -51.47 -47.07 5.92 -16.96 -19.52 -93.71 9.47 167.35 -15.87 Cash after chg. in Working capital 366.17 259.24 163.79 248.97 193.88 164.53 14.49 108.65 1,043.91 166.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -90.80 -64.91 -40.87 -47.84 -53.47 -37.87 -28.47 -24.45 -164.22 -32.15 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 24.30 -27.67 -20.68 -45.31 -27.62 -111.89 -142.50 -116.05 -260.92 -89.46 Net Fixed Assets -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 -69.55 -32.72 Net Investments 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 -214.42 -60.83 Others 65.46 24.95 31.80 39.66 174.30 19.13 15.39 21.67 23.05 4.09 Cash from Financing Activity -306.05 -155.74 -59.52 -183.84 -99.62 -1.39 12.04 -31.45 -526.12 4.56 Net Cash Inflow / Outflow -6.38 10.92 42.72 -28.02 13.17 13.38 -144.43 -63.30 92.65 49.02 Opening Cash & Equivalents 32.14 21.24 -21.47 6.54 -5.46 11.81 156.23 219.53 126.89 77.86 Closing Cash & Equivalent 25.75 32.14 21.24 -21.47 9.42 25.19 11.81 156.23 219.53 126.89

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 187.02 185.02 173.91 163.62 144.15 119.84 123.66 119.10 112.59 84.36 ROA 12.36% 7.99% 5.92% 8.43% 10.38% 8.14% 5.23% 6.95% 58.96% 12.59% ROE 18.30% 12.39% 9.01% 13.25% 16.01% 11.01% 6.65% 8.66% 77.13% 17.83% ROCE 22.94% 18.30% 12.50% 15.65% 19.14% 14.65% 9.09% 10.85% 87.21% 18.53% Fixed Asset Turnover 1.55 1.51 1.29 1.46 1.86 1.99 1.92 1.80 1.72 2.18 Receivable days 71.64 72.99 82.25 80.81 80.55 84.22 83.37 71.93 135.90 177.98 Inventory Days 48.96 46.67 48.83 44.65 41.01 40.66 37.88 39.88 45.40 31.03 Payable days 33.20 32.65 32.75 29.00 27.03 25.03 24.67 24.46 26.27 27.04 Cash Conversion Cycle 87.40 87.01 98.33 96.46 94.52 99.85 96.57 87.35 155.03 181.96 Total Debt/Equity 0.02 0.02 0.02 0.04 0.14 0.10 0.09 0.05 0.07 0.24 Interest Cover 108.34 59.98 53.45 44.35 23.41 24.93 16.84 21.55 38.16 14.84

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 185.75 184.47 172.50 160.77 139.57 117.31 123.07 119.21 113.34 80.86 ROA 12.54% 8.52% 6.43% 8.99% 9.21% 7.08% 4.64% 6.36% 61.71% 15.17% ROE 18.69% 13.28% 9.89% 14.48% 14.80% 9.86% 5.99% 8.07% 82.49% 22.35% ROCE 23.69% 19.59% 13.70% 16.87% 17.72% 13.49% 8.50% 10.41% 92.09% 22.63% Fixed Asset Turnover 1.57 1.54 1.35 1.53 1.82 2.03 1.92 1.76 1.85 2.22 Receivable days 67.22 67.63 73.15 71.84 79.28 78.41 75.30 68.16 108.62 140.48 Inventory Days 53.31 50.81 53.43 51.77 50.12 44.83 42.16 42.80 47.97 39.77 Payable days 32.74 32.21 33.66 32.86 32.45 27.82 26.91 26.15 26.89 25.89 Cash Conversion Cycle 87.79 86.23 92.93 90.75 96.95 95.43 90.54 84.81 129.69 154.35 Total Debt/Equity 0.02 0.02 0.02 0.04 0.16 0.13 0.09 0.05 0.07 0.25 Interest Cover 108.09 62.74 56.54 43.81 20.80 22.33 15.74 20.61 36.10 16.75

Top Investors:

dsp small cap fund **

franklin india smaller companies fund

hdfc small cap fund **

icici prudential pharma healthcare and diaganostics (p.h.d) fund **

Annual Reports:

News Update:

JB Chemicals gets USFDA's nod for Loratadine Tablets
8th Jan 2021, 16:24 PM

The Company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve Company's US sales
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback